U.S., July 26 -- ClinicalTrials.gov registry received information related to the study (NCT07086638) titled 'ROS-Scavenging Nanozyme Combined With Thermotherapy Alleviate Radiation Dermatitis in Patients With Head and Neck Cancer' on July 15.
Brief Summary: Severe radiation dermatitis remains a challenging complication in head and neck cancer with limited treatment options; this study aims to evaluate a novel Prussian blue-based nanozyme combined with near-infrared thermotherapy to promote effective healing of Grade III lesions.
Study Start Date: July 16
Study Type: INTERVENTIONAL
Condition:
Radiation Dermatitis
Intervention:
DRUG: Photo-responsive nanozyme
The nanozyme scavenges ROS at the site of dermatitis and simultaneously resp...